Christopher S. Kiper

Insider Reports History

Reporting-owner location: Los Angeles, CA
Latest reporting-owner signature: /s/ Christopher S. Kiper
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Christopher S. Kiper

Form 4 holding Director, 10%+ Owner

LIFECORE BIOMEDICAL, INC. \DE\

Security class: Common Stock
Shares / value: 4,084,268
Estimated value: $15,193,476
Report date: 04 Jun 2026
Price: $3.72
Ownership: By: Legion Partners, L.P. I

Form 4 holding Director, 10%+ Owner

LIFECORE BIOMEDICAL, INC. \DE\

Security class: Common Stock
Shares / value: 319,286
Estimated value: $1,187,743
Report date: 04 Jun 2026
Price: $3.72
Ownership: By: Legion Partners, L.P. II

Form 4 holding Director, 10%+ Owner

LIFECORE BIOMEDICAL, INC. \DE\

Security class: Common Stock
Shares / value: 103,482
Estimated value: $384,953
Report date: 04 Jun 2026
Price: $3.72
Ownership: Direct

Form 4 holding Director, 10%+ Owner

LIFECORE BIOMEDICAL, INC. \DE\

Security class: Common Stock
Shares / value: 200
Estimated value: $744
Report date: 04 Jun 2026
Price: $3.72
Ownership: By: Legion Partners Holdings, LLC

Insider Reports Filed by Christopher S. Kiper

4 LFCR

LIFECORE BIOMEDICAL, INC. \DE\

Report period: 04 Jun 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 08 Jun 2026, 16:37
Role: Director, 10%+ Owner
Next action: Open filing details

4 LFCR

LIFECORE BIOMEDICAL, INC. \DE\

Report period: 15 Jul 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 17 Jul 2025, 18:36
Role: Director, 10%+ Owner
Next action: Open filing details

4 LFCR

LIFECORE BIOMEDICAL, INC. \DE\

Report period: 03 Oct 2024
Transactions: 2
Transaction value: +$5,999,997
Accepted by SEC: 07 Oct 2024, 16:33
Role: Director, 10%+ Owner
Next action: Open filing details

4 LFCR

LIFECORE BIOMEDICAL, INC. \DE\

Report period: 08 Jul 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 10 Jul 2024, 16:10
Role: Director
Next action: Open filing details

4 LFCR

LIFECORE BIOMEDICAL, INC. \DE\

Report period: 01 Jun 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 05 Jun 2023, 16:17
Role: Director
Next action: Open filing details

4 LFCR

LIFECORE BIOMEDICAL, INC. \DE\

Report period: 01 Feb 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Feb 2023, 18:56
Role: Director
Next action: Open filing details

4 LFCR

LIFECORE BIOMEDICAL, INC. \DE\

Report period: 09 Jan 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 11 Jan 2023, 20:31
Role: Director
Next action: Open filing details

3 LFCR

LIFECORE BIOMEDICAL, INC. \DE\

Report period: 09 Jan 2023
Transactions: 0
Transaction value: $0
Accepted by SEC: 11 Jan 2023, 20:30
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .